SIGNATUREFD, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,000
-28.6%
532
+54.2%
0.00%
Q4 2021$7,000
-41.7%
345
-0.6%
0.00%
Q3 2021$12,000
-7.7%
347
+6.4%
0.00%
-100.0%
Q2 2021$13,000
-31.6%
326
-17.0%
0.00%0.0%
Q1 2021$19,000
+18.8%
393
+25.6%
0.00%0.0%
Q4 2020$16,000
+100.0%
3130.0%0.00%
Q3 2020$8,000
+33.3%
3130.0%0.00%
Q2 2020$6,000
+100.0%
313
+19.0%
0.00%
Q1 2020$3,0002630.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders